Skip to main content
. 2020 Aug 4;25(6):503–507. doi: 10.1177/1074248420947628

Table 2.

Sensitivity Analysis of the Studies Comparing Mortality Between Patients With Hypertension and Concurrent COVID-19 Infection Who Were Receiving ACEIs Versus ARBs.

RR 95% CI
Removal of the 2 studies with the biggest weight 0.67 [0.40,1.12]
Removal of the 2 studies with the lowest weight 1.10 [0.87,1.39]